Menu Search
Equities

Ipopema Securities SA

0MMY:LSE

Ipopema Securities SA

Actions
  • Price (PLN)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Oct 10 2022.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ipopema Securities SA is a Poland-based company engaged in financial services. The Company specializes in investment banking services such as preparation and execution of transactions on the capital market using share instruments, debentures and hybrid instruments. Ipopema Securities SA also provides brokerage services as well as company analyses. The Company’s offer is above all addressed to domestic and foreign corporate customers and also includes the access to developed foreign stock markets as well as emerging markets. As of December 31, 2011, the Company operated three subsidiaries, wholly owned Ipopema Towarzystwo Funduszy Inwestycyjnych SA and Ipopema Asset Management, as well as 50.02%-owned Ipopema Business Consulting Sp. z o.o.

  • Revenue in PLN (TTM)306.31m
  • Net income in PLN17.43m
  • Incorporated2005
  • Employees240.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.